News & Updates

Everolimus helps fight recurrent thymic neuroendocrine neoplasia
Everolimus helps fight recurrent thymic neuroendocrine neoplasia
26 Oct 2021 byJairia Dela Cruz

Treatment with everolimus appears to have beneficial effects on recurrent thymic neuroendocrine neoplasia (NEN), particularly well-differentiated tumours, with patients having a low Ki-67 index more likely to have a better outcome with the drug, as shown in a small study.

Everolimus helps fight recurrent thymic neuroendocrine neoplasia
26 Oct 2021
Therapeutic heparin may reduce death, bleeding risks in moderate COVID-19
Therapeutic heparin may reduce death, bleeding risks in moderate COVID-19
26 Oct 2021
Minimally invasive surgery feasible for nonendometroid endometrial cancers
Minimally invasive surgery feasible for nonendometroid endometrial cancers
26 Oct 2021
Total diet replacement helps shed pounds among individuals with obesity
Total diet replacement helps shed pounds among individuals with obesity
26 Oct 2021

A total diet replacement programme produces greater weight loss among people with obesity as compared with support from a practice nurse, with the benefit persisting to at least 3 years, a study has found.

Total diet replacement helps shed pounds among individuals with obesity
26 Oct 2021